View in EDS

Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program.

Saved in:
Bibliographic Details
Title: Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program.
Authors: Thompson MT; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada., Virginia D; University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada., Nick B; Biogen, 225 Binney Street, Cambridge, MA, USA., Melissa G; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada., Engineer N; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada., Shen C; Biogen, 225 Binney Street, Cambridge, MA, USA., Reedie S; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada. Electronic address: scott.reedie@biogen.com.
Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Nov; Vol. 67, pp. 104080. Date of Electronic Publication: 2022 Jul 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35973386
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Thompson+MT%22">Thompson MT</searchLink>; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada.<br /><searchLink fieldCode="AU" term="%22Virginia+D%22">Virginia D</searchLink>; University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Nick+B%22">Nick B</searchLink>; Biogen, 225 Binney Street, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Melissa+G%22">Melissa G</searchLink>; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada.<br /><searchLink fieldCode="AU" term="%22Engineer+N%22">Engineer N</searchLink>; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada.<br /><searchLink fieldCode="AU" term="%22Shen+C%22">Shen C</searchLink>; Biogen, 225 Binney Street, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Reedie+S%22">Reedie S</searchLink>; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada. Electronic address: scott.reedie@biogen.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580247%22">Multiple sclerosis and related disorders</searchLink> [Mult Scler Relat Disord] 2022 Nov; Vol. 67, pp. 104080. <i>Date of Electronic Publication: </i>2022 Jul 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2E+V%22">Elsevier B. V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101580247 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-0356 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222110348%22">22110348 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler Relat Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35973386
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.msard.2022.104080
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104080
    Titles:
      – TitleFull: Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Thompson MT
      – PersonEntity:
          Name:
            NameFull: Virginia D
      – PersonEntity:
          Name:
            NameFull: Nick B
      – PersonEntity:
          Name:
            NameFull: Melissa G
      – PersonEntity:
          Name:
            NameFull: Engineer N
      – PersonEntity:
          Name:
            NameFull: Shen C
      – PersonEntity:
          Name:
            NameFull: Reedie S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2211-0356
          Numbering:
            – Type: volume
              Value: 67
          Titles:
            – TitleFull: Multiple sclerosis and related disorders
              Type: main
ResultId 1